Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Tandem Diabetes Care Inc’s stock clocked out at $22.26, up 4.41% from its previous closing price of $21.32. In other words, the price has increased by $4.41 from its previous closing price. On the day, 1.47 million shares were traded.
Ratios:
To gain a deeper understanding of TNDM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 2.30. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Neutral rating and assigned the stock a target price of $20.
On March 05, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $45 to $22.
Citigroup Downgraded its Buy to Neutral on March 04, 2025, whereas the target price for the stock was revised from $35 to $24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Kyrillos Jean-Claude bought 10,538 shares for $18.12 per share. The transaction valued at 190,966 led to the insider holds 10,538 shares of the business.
BLICKENSTAFF KIM D sold 30,000 shares of TNDM for $941,400 on Nov 21 ’24. The Director now owns 165,190 shares after completing the transaction at $31.38 per share. On Nov 20 ’24, another insider, BLICKENSTAFF KIM D, who serves as the Director of the company, sold 10,000 shares for $30.00 each. As a result, the insider received 300,000 and left with 195,190 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 9.54.
Stock Price History:
Over the past 52 weeks, TNDM has reached a high of $53.69, while it has fallen to a 52-week low of $15.75. The 50-Day Moving Average of the stock is 16.64%, while the 200-Day Moving Average is calculated to be -31.47%.
Shares Statistics:
A total of 66.57M shares are outstanding, with a floating share count of 66.06M. Insiders hold about 0.83% of the company’s shares, while institutions hold 108.50% stake in the company.
